CANFのROE（自己資本利益率）は？

CAN FITE BIOPHARMA LTD ADRのROEは-177.15%です。

CANFの配当利回りは？

CAN FITE BIOPHARMA LTD ADRの配当利回りは0.00%です。

CANFの品質スコア（Quality Score）は？

当社のAIはCANFの総合財務品質を100点中15点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

CANFは今が買い時ですか？

当社AIのタイミングスコアは100点中26点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

CANFはどのセクターに属しますか？

CAN FITE BIOPHARMA LTD ADRはHealthcare >> Biotechnologyセクターに分類されます（NYSE MKT市場）

CANF (NYSE MKT) 株価分析 | CAN FITE BIOPHARMA LTD ADR

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2025-12-31)

CANF AI Analysis Summary

Our AI summary for CANF: CAN FITE BIOPHARMA LTD ADR (NYSE MKT), Healthcare >> Biotechnology sector. The stock currently trades at ROE of -177.15%, a dividend yield of 0.00%. Its financial Quality Score stands at 15/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

CANF

CAN FITE BIOPHARMA LTD ADR

US:NYSE MKT STOCK Healthcare >> Biotechnology News 81

USD 3.15

-0.13 (-3.96%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-177.2%

ROE

-104.1%

ROA

0.00%

Div Yield

CAN FITE BIOPHARMA LTD ADR
TYPE: STOCK
MARKET: NYSE MKT

Compare Watchlist Myport

USD 3.15 Price -0.13 (-3.96%) Day Change	NEWS SCORE: 81

CANF, ファンダメンタルスコアはnot good ( ファンダメンタル = 15) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

15 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...

Deepscope 分析

38%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	81
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	3.15
PBV / Sector	1.21 / 5.20 GOOD
Earning Per Share	-12.02

PE / Sector	N/A / 19.97
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	0.63 M GREAT
Average 1W Daily Value	0.08 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-2,426.67 / 98.71
NPM Average (%) / Sector	-1,471.74 / -1,721.76
NPM Change Average (%) / Sector	34.22 / 5,211.62 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-104.12 / 27.02
ROA Average (%) / Sector	-94.30 / -368.17
ROA Change Average (%) / Sector	0.96 / 5,404.12
ROE (%) / Sector	-177.15 / 3.47
ROE Average (%) / Sector	-168.32 / 6.51
ROE Change Average (%) / Sector	-1.94 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 07:59:36
Symbol	CANF
Name	CAN FITE BIOPHARMA LTD ADR
Sector	Healthcare >> Biotechnology
Market	NYSE MKT
Listed Shares	2.14 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	6.79 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 26 Ben Gurion Street, Ramat Gan, Israel, 5257346

Phone: 972 3 924 1114

Website: https://www.canfite.com

Sector: Healthcare >> Biotechnology

Description: Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cancer; and Phase IIa for the treatment of pancreatic cancer; as well as in Phase IIb trial for the treatment of metabolic associated steatohepatitis; and CF602, which is in pre-clinical trial for the treatment of erectile dysfunction. In addition, It offers cannabinoids for treatment of conditions associated with elevated expression of the A3 adenosine receptors. Further, the company develops commercial predictive biomarker blood test kit for A3AR. It has license and collaboration agreement with CMS Medical to develop, manufacture, and commercialize Piclidenoson and Namodenoson. The company was formerly known as Can-Fite Technologies Ltd. and changed its name to Can-Fite BioPharma Ltd. in January 2001. The company was incorporated in 1994 and is headquartered in Ramat Gan, Israel.